Document is current
Any future updates will be listed below
-
Authors
Nichols, Anthony C.
Lang, Pencilla
Prisman, Eitan
Berthelet, Eric
Tran, Eric
Hamilton, Sarah
Wu, Jonn
Fung, Kevin
de Almeida, John R.
Bayley, Andrew
Goldstein, David P.
Eskander, Antoine
Husain, Zain
Bahig, Houda
Christopoulous, Apostolos
Hier, Michael
Sultanem, Khalil
Richardson, Keith
Mlynarek, Alex
Krishnan, Suren
Le, Hien
Yoo, John
MacNeil, S. Danielle
Mendez, Adrian
Winquist, Eric
Read, Nancy
Venkatesan, Varagur
Kuruvilla, Sara
Warner, Andrew
Mitchell, Sylvia
Corsten, Martin
Rajaraman, Murali
Johnson-Obaseki, Stephanie
Eapen, Libni
Odell, Michael
Chandarana, Shamir
Banerjee, Robyn
Dort, Joseph
Matthews, T. Wayne
Hart, Robert
Kerr, Paul
Dowthwaite, Samuel
Gupta, Michael
Zhang, Han
Wright, Jim
Parker, Christina
Wehrli, Bret
Kwan, Keith
Theurer, Julie
Palma, David A. https://orcid.org/0000-0002-9542-0627
-
Funding
Funding for this research was provided by:
London Health Sciences Foundation
Ontario Institute for Cancer Research
London Health Sciences Centre - department of otolaryngology head and neck surgery
Canadian Cancer Clinical Trials Network
- License Information
-
More Information
Article History
Received: 20 December 2019
Accepted: 6 February 2020
First Online: 14 February 2020
Ethics approval and consent to participate
: Ethics approval has been obtained from the Ontario Cancer Research Ethics Board (#0905). Written consent to participate will be obtained from individual study participants and will include consent to undergo study interventions as well as biomarker assessment. Consent will be obtained at individual participating institutions by study investigators or clinical trials staff members.
: Not applicable.
: The authors declare that they have no competing interests.
